&w=3840&q=100)
Advent to invest $175 million in animal health drugmaker Felix Pharma
Jaden Mathew Paul Alappuzha
Private equity firm Advent International is set to invest $175 million in Felix Pharmaceuticals, securing a minority stake in the Dublin-based company that specialises in off-patent medicines for pets.
The deal, which includes both primary and secondary transactions, positions Felix to accelerate its global ambitions as a differentiated player in the nascent but expanding companion animal generics space.
The company expects to commission a new injectable facility by the third quarter of 2025, adding to its USFDA-approved oral solid manufacturing plant.
'Healthcare has been a long-standing focus for us, and strong parallels we see between success in human Gx globally and emerging opportunity in animal health Gx,' said Shweta Jalan, managing partner, Advent.
'Felix is well positioned to lead this space,' said Jalan, adding, 'Its rapid growth and high customer satisfaction make it a differentiated platform.'
Less than 10 per cent of the companion animal market is currently held by generic players, said Pankaj Patwari, managing director, Advent.
The company develops bio-equivalent generics across a wide range of therapeutic categories, including NSAIDs, antibacterials, and antiparasitics, for dogs, cats, and horses.
'We were looking for a partner who brings not just capital, but also deep operating expertise and the right mindset and networks to help us grow faster and stronger,' said Agrawal.
Felix has offices in Kansas City and Gurugram, alongside its Dublin headquarters, and employs around 500 people globally.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
18 minutes ago
- Time of India
EV maker Polestar to produce new model in Europe
Sweden-based electric vehicle maker Polestar said on Thursday its upcoming SUV model Polestar 7 will be manufactured at Volvo Cars ' under-construction factory in Slovakia, making it its first car to be made in Europe. Polestar said in a statement the two companies, which are both controlled by China's Geely and its owner Li Shufu, had signed a memorandum of understanding to the effect, and that it plans to launch the model in 2028. "Polestar is taking the next step in diversifying its contract manufacturing footprint by expanding it to Europe," it said, adding that the move would strengthen its position in its our home market. Polestar doesn't own factories, its cars are produced at factories owned by Volvo Cars and Geely in China and the United States. One model will also manufactured in South Korea from this year.
Hans India
22 minutes ago
- Hans India
India's office leasing jumps 40 pc in H1 2025, new supply jumps 25 pc: Report
New Delhi: India's commercial real estate market witnessed strong growth in the first half of 2025, with net office leasing across the top seven cities rising by 40 per cent year-on-year (YoY), a new report said on Thursday. According to data compiled by Anarock Research, net office absorption grew from around 19.08 million sq. ft. in H1 2024 to approximately 26.8 million sq. ft. in H1 2025. New office supply also increased by 25 per cent during the same period, reaching nearly 24.51 million sq. ft. Experts say the strong office market performance reflects India's steady economic growth and its rising global profile as a business destination. Peush Jain, Managing Director, Commercial Leasing & Advisory at Anarock Group, said the country continues to attract large-scale office leasing by global capability centres (GCCs) and US-based corporates. He also noted that India's economic stability stands in contrast to policy uncertainty in the US, making it an increasingly attractive destination for long-term investments. Bengaluru led the leasing activity with around 6.55 million sq. ft. of office space absorbed in H1 2025 -- a 64 per cent increase compared to 4 million sq. ft. in the same period previous year. Pune stood out with the highest annual growth in net absorption, soaring by 188 per cent to 3.8 million sq. ft., up from 1.32 million sq. ft. the previous year. Kolkata, however, was the only city among the top seven to see a decline in leasing, dropping 51 per cent to just 0.45 million sq. ft. In terms of new office space completions, Bengaluru again took the lead by adding approximately 6.91 million sq. ft. in H1 2025, a 26 per cent rise from the previous year. Pune posted an exceptional 533 per cent jump in new supply, going from just 0.9 million sq. ft. in H1 2024 to over 5.7 million sq. ft. this year, the report stated. Sector-wise, the IT/ITeS sector continued to drive demand, accounting for 29 per cent of overall office leasing. This was followed by the coworking sector at 22 per cent and BFSI at 18 per cent.
Time of India
33 minutes ago
- Time of India
China targets Taiwan's chip secrets with $24 billion acquisition plot, ET Manufacturing
Advt Advt Join the community of 2M+ industry professionals. Subscribe to Newsletter to get latest insights & analysis in your inbox. Get updates on your preferred social platform Follow us for the latest news, insider access to events and more. The Ministry of Economic Affairs (MOEA) announced on Wednesday that it will conduct a "thorough examination" of any proposed acquisition of the Taiwanese tech firm Source Photonics Co, Ltd, amid growing concerns about a Chinese company's interest in purchasing the Hsinchu-based firm, as reported by Focus to Focus Taiwan, Suzhou Dongshan Precision Manufacturing Co., Ltd. (DSBJ), the largest printed circuit board manufacturer in China, has expressed intentions to acquire Source Photonics for RMB5.9 billion (approximately NT$24 billion). As per Focus Taiwan, this acquisition would trigger a change in ownership structure that falls under national security MOEA confirmed on Wednesday that it has not yet received a formal application from Source Photonics concerning the rumoured buyout but has already informed the company that any such deal would be subject to regulatory review, Focus Taiwan Taiwanese regulations governing Chinese investments, prior approval from the MOEA is mandatory for any ownership changes involving Chinese capital, the ministry reiterated. According to Focus Taiwan, the MOEA has been closely monitoring the company's operations and last month issued a formal letter requesting updated details about its shareholding reported by Focus Taiwan, once an application is submitted, the MOEA plans to coordinate with the National Security Bureau (NSB), the Mainland Affairs Council (MAC), and relevant industrial technology bodies to determine whether the deal poses national security risks or could negatively impact Taiwan's industrial development. If such risks are identified, the investment permit may be revoked in accordance with current Progressive Party (DPP) legislator Hsu Chih-chieh raised alarms over the potential transfer of sensitive technology, noting that Source Photonics holds advanced 3-nanometer chip technology . He urged the government to act with caution and proposed the development of a national list of critical technologies to safeguard against Chinese acquisitions, an issue highlighted in Focus Taiwan's Taiwan further reported that the MOEA has been tracking the situation since 2016, when Source Photonics' top shareholders were first categorised as Chinese capital.
